Pyridostigmine Bromide
Product Images NDC 0115-1404

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 0115-1404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pyridostigmine Bromide Extended Release Tablets 1)

Chemical structure of Pyridostigmine Bromide showing a pyridinium ring with a methyl group and an OCON(CH3)2 substituent, paired with a bromide ion (Br-).*

FDA Label Image

Principal Display Panel (180 mg Tablet Bottle Label)

Label for Pyridostigmine Bromide Extended-Release Tablets 180 mg by Amneal Pharmaceuticals of New York LLC. The label specifies a 30-tablet quantity and includes warnings about moisture sensitivity and instructions to keep the silica gel enclosed. It notes the medication is prescription only and provides storage temperature guidelines (20° to 25°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.